from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3157/nuoM

LFCtreatmentdescriptionclass of inhibitor

-1.478

Amikacinug/mL Amikacintranslation

-2.060

Cap5-10ug/mL Capreomycintranslation

-2.198

Rox10-50 ug/mL Roxithromycintranslation

-1.358

SM2-5 ug/mL Streptomycintranslation

-3.830

Tet5-10 ug/mL Tetracyclinetranslation

-0.250

Rif0.2-5ug/mL Rifampicintranscription

-0.191

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.282

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.597

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.372

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.385

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.221

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.314

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.459

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.212

Nigericin50 uM Nigericinrespiration

-1.149

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

1.448

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.427

menadione6-10 ug/mL Menadionerespiration

-0.665

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.445

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.575

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.525

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.216

NRP_1Non-replicating persistence stage 1dosRassociated

0.651

Amp0.2mg/mL AmpicillincellWall

0.556

Cephalexin20-100 ug/mL CephalexincellWall

-0.311

Cerulenin0.32-5 ug/mL CerulenincellWall

0.692

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.111

EMB10-20 ug/mL EthambutolcellWall

-0.390

Eta12-40 ug/mL EthionamidecellWall

-0.095

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.062

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.181

BZA0.12 mg/mL BenzamidearomaticAmides

0.498

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.471

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.537

H2O24 mM hydrogen peroxideDNAdamaging

-0.361

Levo10 ug/mL LevofloxacinDNAdamaging

0.114

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.155

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.343

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.434

Antimycin12.5-50 ug/mL Antimycin A?

1.415

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.609

PA_110-50 ug/mL Antitubercular compound PA-1?

0.714

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.755

PA8240.2-2 ug/mL PA-824?

-0.502

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.635

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.790

Verapamil50 uM Verapamil?

1.669

mercaptoethanol2 mM 2-Mercaptoethanol?

1.737

methoxatin10-20 ug/mL Methoxatin?